Congenital portosystemic shunts associated with liver tumours
Autor: | L.F. Pupulim, Dominique Valla, Sylvain Terraz, Marie-Pierre Vullierme, Valérie Paradis, Valérie Vilgrain |
---|---|
Rok vydání: | 2013 |
Předmět: |
Adult
Male medicine.medical_specialty Adolescent Adenoma Vascular Malformations complex mixtures ddc:616.0757 Systemic circulation Adenoma Liver Cell Young Adult stomatognathic system Focal Nodular Hyperplasia/complications/pathology Vascular Malformations/complications/pathology Biopsy medicine Humans Radiology Nuclear Medicine and imaging Portal Vein/abnormalities/pathology Liver Neoplasms/complications/pathology Adenoma Liver Cell/complications/pathology Retrospective Studies medicine.diagnostic_test Portal Vein business.industry Liver Neoplasms Biopsy Needle Focal nodular hyperplasia Ultrasonography Doppler Retrospective cohort study Magnetic resonance imaging General Medicine Liver tumours Hepatocellular adenoma medicine.disease Magnetic Resonance Imaging carbohydrates (lipids) stomatognathic diseases Focal Nodular Hyperplasia Female Radiology Tomography X-Ray Computed business |
Zdroj: | Clinical Radiology, Vol. 68, No 7 (2013) pp. e362-9 |
ISSN: | 0009-9260 |
DOI: | 10.1016/j.crad.2013.01.024 |
Popis: | Aim To evaluate the diagnosis and presentation of liver tumours in patients with congenital portosystemic shunts (CPS). Materials and methods Eight patients were diagnosed in Hopital Beaujon as having CPS. All patients underwent Doppler ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and histological examination of liver tumours. CPS were classified according to anatomy and the amount of portal flow deviated to the systemic circulation as: total, subtotal, or partial. Liver tumours were diagnosed by needle core biopsy ( n = 5) or surgery ( n = 3). Clinical follow-up was available in all patients but one (mean follow-up 36 months; range 1–5 years). Results Six patients had total CPS, one patient had a subtotal CPS, and the last had a partial CPS. All patients presented with multiple liver nodules (range four to >15). The tumours were characterized as focal nodular hyperplasia (FNH; n = 4), FNH with hepatocellular adenoma ( n = 2), and regenerative nodular hyperplasia ( n = 2). In four of seven patients (57%) that had follow-up, tumours showed enlargement or new lesions appeared. Conclusion In this series of CPS patients, tumours were all benign, multiple, and of hepatocellular origin, and different tumours were present simultaneously in two patients. Tumour enlargement or new nodules were common during follow-up. |
Databáze: | OpenAIRE |
Externí odkaz: |